Jump to ContentJump to Main Navigation
Show Summary Details

Buchner, Johannes

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

See all formats and pricing



Select Volume and Issue


30,00 € / $42.00 / £23.00

Get Access to Full Text

Identification of three novel mutations in the dihydropyrimidine dehydrogenase gene associated with altered pre-mRNA splicing or protein function

André B.P. Van Kuilenburg1 / Rutger Meinsma2 / Eva Beke3 / Barbara Bobba4 / Patrizia Boffi5 / Gregory M. Enns6 / David R. Witt7 / Doreen Dobritzsch8









Corresponding author

Citation Information: Biological Chemistry. Volume 386, Issue 4, Pages 319–324, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2005.038, July 2005

Publication History

November 5, 2004
February 3, 2005
Published Online:


Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of the pyrimidine bases uracil and thymine, as well as of the widely used chemotherapeutic drug 5-fluorouracil (5FU). Analysis of the DPD gene (DPYD) in two patients presenting with complete DPD deficiency and the parents of an affected child showed the presence of three novel mutations, including one splice site mutation IVS11+1G→T and the missense mutations 731A→C (E244V) and 1651G→A (A551T). The G→T mutation in the invariant GT splice donor site flanking exon 11 (IVS11+1G→T) created a cryptic splice site within exon 11. As a consequence, a 141-bp fragment encoding the aminoacid residues 400–446 of the primary sequence of the DPD protein was missing in the mature DPD mRNA. Analysis of the crystal structure of pig DPD suggested that the E244V mutation might interfere with the electron flow between NADPH and the pyrimidine binding site of DPD. The A551T point mutation might prevent binding of the prosthetic group FMN and affect folding of the DPD protein. The identification of these novel mutations in DPYD will allow the identification of patients with an increased risk of developing severe 5FU-associated toxicity.

Keywords: dihydropyrimidine dehydrogenase; DPYD; 5-fluorouracil; pharmacogenetics; pyrimidines; thymine; uracil

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

André B.P. van Kuilenburg, Judith Meijer, Michael W.T. Tanck, Doreen Dobritzsch, Lida Zoetekouw, Lois-Lee Dekkers, Jeroen Roelofsen, Rutger Meinsma, Machteld Wymenga, Wim Kulik, Barbara Büchel, Raoul C.M. Hennekam, and Carlo R. Largiadèr
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
D. Rosmarin, C. Palles, A. Pagnamenta, K. Kaur, G. Pita, M. Martin, E. Domingo, A. Jones, K. Howarth, L. Freeman-Mills, E. Johnstone, H. Wang, S. Love, C. Scudder, P. Julier, C. Fernandez-Rozadilla, C. Ruiz-Ponte, A. Carracedo, S. Castellvi-Bel, A. Castells, A. Gonzalez-Neira, J. Taylor, R. Kerr, D. Kerr, and I. Tomlinson
Gut, 2015, Volume 64, Number 1, Page 111
Kun-Nan Tsai, Guang-Wu Chen, and Calvin Yu-Chian Chen
Journal of Biomolecular Structure and Dynamics, 2012, Volume 29, Number 5, Page 1089
Ursula Amstutz, Tanja K Froehlich, and Carlo R Largiadèr
Pharmacogenomics, 2011, Volume 12, Number 9, Page 1321
André B. P. van Kuilenburg, Judith Meijer, Adri N. P. M. Mul, Rutger Meinsma, Veronika Schmid, Doreen Dobritzsch, Raoul C. M. Hennekam, Marcel M. A. M. Mannens, Marion Kiechle, Marie-Christine Etienne-Grimaldi, Heinz-Josef Klümpen, Jan Gerard Maring, Veerle A. Derleyn, Ed Maartense, Gérard Milano, Raymon Vijzelaar, and Eva Gross
Human Genetics, 2010, Volume 128, Number 5, Page 529
Julie Fidlerova, Petra Kleiblova, Matej Bilek, Stanislav Kormunda, Zuzana Formankova, Jan Novotny, and Zdenek Kleibl
Cancer Chemotherapy and Pharmacology, 2010, Volume 65, Number 4, Page 661
André B. P. van Kuilenburg, Judith Meijer, Adri N. P. M. Mul, Raoul C. M. Hennekam, Jan M. N. Hoovers, Christine E. M. de Die-Smulders, Peter Weber, Andrea Capone Mori, Jörgen Bierau, Brian Fowler, Klaus Macke, Jörn Oliver Sass, Rutger Meinsma, Julia B. Hennermann, Peter Miny, Lida Zoetekouw, Raymon Vijzelaar, Joost Nicolai, Bauke Ylstra, and M. Estela Rubio-Gozalbo
Human Genetics, 2009, Volume 125, Number 5-6, Page 581
Su-arpa Ploylearmsaeng, Uwe Fuhr, and Alexander Jetter
Clinical Pharmacokinetics, 2006, Volume 45, Number 6, Page 567

Comments (0)

Please log in or register to comment.